Minnesota-based Medtronic (NYSE:MDT) celebrated the opening of a new manufacturing facility in China where the company will focus most of its hemodialysis system manufacturing.
Minnesota
Medtronic settles insulin pump beef for $2.8M
Medtronic has big dreams for China’s diabetes market | MassDevice.com On Call
Press Release: St. Jude Medical announces CE Mark approval and 1st use of the FlexAbility ablation catheter
St. Jude lands E.U. nod for flexible ablation catheter
European regulators put their stamp of approval on St. Jude Medical’s (NYSE:STJ) new FlexAbility ablation catheter, paving the way to 1st use of the next-generation device.
Medtech funding soars in Minnesota in Q2
Minnesota medical device startups got a big boost in funding in the 2nd quarter of 2014, with 134% more money invested than during the same period last year, according to a new report.
The numbers suggest greater interest in early-stage deals, according to LifeScience Alley, the North Star State’s medical device and life sciences lobbying group.
St. Jude drops $200M on NeuroTherm for spinal pain device
Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.
Diabetes: Medtronic insulin pump beats daily injections for managing Type II
In the largest study of its kind to date, researchers announced today that Medtronic’s (NYSE:MDT) MiniMed insulin pump beat multiple daily injections in managing blood glucose levels in patients with Type II diabetes.